Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Abstarct Background To examine long-term-survival of cT4 cN0/1 cM0 non-small-cell lung carcinoma (NSCLC) patients undergoing definitive radiochemotherapy (ccRTx/CTx) in comparison to the trimodality treatment, neoadjuvant radiochemotherapy followed by surgery, at a high volume lung cancer center. Me...

Full description

Bibliographic Details
Main Authors: Nika Guberina, Christoph Pöttgen, Martin Schuler, Maja Guberina, Georgios Stamatis, Till Plönes, Martin Metzenmacher, Dirk Theegarten, Thomas Gauler, Kaid Darwiche, Clemens Aigner, Wilfried E. E. Eberhardt, Martin Stuschke
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Radiation Oncology
Subjects:
Definitive radiochemotherapy
Non-small cell lung cancer
TNM-staging
Online Access:https://doi.org/10.1186/s13014-022-02080-9

Internet

https://doi.org/10.1186/s13014-022-02080-9

Similar Items